Table 3.

Diagnostic sensitivity of hepatocellular carcinoma by the four modalities

Modality	Diagnostic sensitivity
	All nodules (n = 34)		Moderately-differentiated HCC (n = 24)
	n (%)	95% CI	n (%)	95% CI
Contrast-enhanced computed tomography	18 (52.9)	35.1-70.2	15 (62.5)	40.6-81.2
Sonazoid contrast-enhanced ultrasonography	23 (67.6)	49.5-82.6	19 (79.2)	57.8-92.9
Gd-EOB-DTPA magnetic resonance imaging	26 (76.5)	58.8-89.3	18 (75.04)	53.3-90.2
Computed tomography arterioportal angiography	30 (88.2)	72.5-96.7	23 (95.8)	78.9-99.9

Gd-EOB-DTPA: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid; HCC: Hepatocellular carcinoma.